Exosomes: Mechanisms of Uptake

Journal of Circulating Biomarkers

Volumn 4, Issue , 2015, Pages

  McKelvey, Kelly J ^a   Powell, Katie L ^a   Ashton, Anthony W ^a   Morris, Jonathan M ^a   McCracken, Sharon A ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

endocytosis; Exosome; immunology

Indexed keywords

EID: 85028828913     PISSN: None     EISSN: 18494544     Source Type: Journal    
DOI: 10.5772/61186     Document Type: Review

References (84)

1. Feynman R, (1960). There's plenty of room at the bottom. Eng. Sci. (CalTech), 23: 22–36.
2. Whiteside T, (2013). Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem. Soc. Trans., 41: 245–251.
3. Pitt JM, Charrier M, Viaud S, André F, Besse B, Chaput N, Zitvogel L, (2014). Dendritic cell–derived exosomes as immunotherapies in the fight against cancer. J. Immunol., 193: 1006–1011.
4. Chaput N, Flament C, Viaud S, Taieb J, Roux S, Spatz A, André F, LePecq J-B, Boussac M, Garin J, Amigorena S, Théry C, Zitvogel L, (2006). Dendritic cell-derived exosomes: biology and clinical implementations. J. Leuko. Biol., 80: 471–478.
5. Quah BJ, O'Neill HC, (2005). The immunogenicity of dendritic cell-derived exosomes. Blood Cell. Mol. Dis., 35: 94–110.
6. Redman C, Sargent I, (2007). Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol., 76: 61–67.
7. Bock JB, Matern HT, Peden AA, Scheller RH, (2001). A genomic perspective on membrane compartment organization. Nature, 409: 839–841.
8. Hurley JH, (2008). ESCRT complexes and the biogenesis of multivesicular bodies. Curr. Opin. Cell Biol., 20: 4–11.
9. Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S, (2001). Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol., 166: 7309–7318.
10. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M, (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science, 319: 1244–1247.
11. Saunderson SC, Schuberth PC, Dunn AC, Miller L, Hock BD, MacKay PA, Koch N, Jack RW, McLellan AD, (2008). Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J. Immunol., 180: 8146–8152.
12. Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, González S, Sánchez-Cabo F, González M, Bernad A, Sánchez-Madrid F, (2011). Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun., 2: 282.
13. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C, (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol., 12: 19–30.
14. Bobrie A, Colombo M, Raposo G, Théry C, (2011). Exosome secretion: Molecular mechanisms and roles in immune responses. Traffic, 12: 1659–1668.
15. Gross JC, Chaudhary V, Bartscherer K, Boutros M, (2012). Active Wnt proteins are secreted on exosomes. Nat. Cell Biol., 14: 1036–1045.
16. Fader CM, Sánchez DG, Mestre MB, Colombo MI, (2009). TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. BBA - Mol. Cell Res., 1793: 1901–1916.
17. Tian T, Zhu Y-L, Hu F-H, Wang Y-Y, Huang N-P, Xiao Z-D, (2013). Dynamics of exosome internalization and trafficking. J. Cell. Physiol., 228: 1487–1495.
18. Saunderson SC, Dunn AC, Crocker PR, McLellan AD, (2014). CD169 mediates the capture of exosomes in spleen and lymph node. Blood, 123: 208–216.
19. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell R, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang H, (2011). Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther., 19: 1769–1779.
20. Lee T, Choi M, Kopacz A, Yun S, Liu W, Decuzzi P, (2013). On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci. Rep., 3: 2079.
21. van der Meel R, Fens MH, Vader P, van Solinge WW, Eniola-Adefeso O, Schiffelers RM, (2014). Extracellular vesicles as drug delivery systems: Lessons from the liposome field. J. Control. Release, 195: 72–85.
22. Blanc L, Barres C, Bette-Bobillo P, Vidal M, (2007). Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2. Blood, 110: 3407–3416.
23. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S, (2002). Identification of a factor that links apoptotic cells to phagocytes. Nature, 417: 182–187.
24. Wu Y, Wu W, Wong WM, Ward E, Thrasher AJ, Goldblatt D, Osman M, Digard P, Canaday DH, Gustafsson K, (2009). Human γδ T Cells: A lymphoid lineage cell capable of professional phagocytosis. J. Immunol., 183: 5622–5629.
25. Chen T, Guo J, Yang M, Zhu X, Cao X, (2011). Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J. Immunol., 186: 2219–2228.
26. Maecker H, Todd S, Levy S, (1997). The tetraspanin superfamily: Molecular facilitators. FASEB J., 11: 428–442.
27. Segura E, Nicco C, Lombard B, Véron P, Raposo G, Batteux F, Amigorena S, Théry C, (2005). ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood, 106: 216–223.
28. Atay S, Gercel-Taylor C, Kesimer M, Taylor DD, (2011). Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp. Cell Res., 317: 1192–1202.
29. Morelli AE, Larregina AT, Shufesky WJ, Sullivan MLG, Stolz DB, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC, Falo LD, Thomson AW, (2004). Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood, 104: 3257–3266.
30. Nolte-'t Hoen ENM, Buschow SI, Anderton SM, Stoorvogel W, Wauben MHM, (2009). Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood, 113: 1977–1981.
31. Zech D, Rana S, Büchler M, Zöller M, (2014). Tumor-exosomes and leukocyte activation: An ambivalent crosstalk. Cell. Commun. Signal., 10: 37.
32. Heijnen H, Schiel A, Fijnheer R, Geuze H, Sixma J, (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood, 94: 3791–3799.
33. Berditchevski F, Zutter MM, Hemler ME, (1996). Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell, 7: 193–207.
34. Imai T, Yoshie O, (1993). C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol., 151: 6470–6481.
35. Imai T, Kakizaki M, Nishimura M, Yoshie O, (1995). Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J. Immunol., 155: 1229–1239.
36. Tai X, Toyooka K, Yashiro Y, Abe R, Park CS, Hamaoka T, Kobayashi M, Neben S, Fujiwara H, (1997). CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis. J. Immunol., 159: 3799–3807.
37. Christianson HC, Svensson KJ, van Kuppevelt TH, Li J-P, Belting M, (2013). Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proceedings of the National Academy of Sciences, 110: 17380–17385.
38. Maguire CA, Balaj L, Sivaraman S, Crommentuijn MHW, Ericsson M, Mincheva-Nilsson L, Baranov V, Gianni D, Tannous BA, Sena-Esteves M, Breakefield XO, Skog J, (2012). Microvesicle-associated AAV Vector as a Novel Gene Delivery System. Molecular Therapy, 20: 960–971.
39. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, Hivroz C, (2002). TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex. J. Immunol., 168: 3235–3241.
40. de Candia P, Torri A, Gorletta T, Fedeli M, Bulgheroni E, Cheroni C, Marabita F, Crosti M, Moro M, Pariani E, Romanò L, Esposito S, Mosca F, Rossetti G, Rossi R, Geginat J, Casorati G, Dellabona P, Pagani M, Abrignani S, (2013). Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS One, 8: e75348.
41. Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL, (2009). Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol., 183: 3720–3730.
42. Kshirsagar SK, Alam SM, Jasti S, Hodes H, Nauser T, Gilliam M, Billstrand C, Hunt JS, Petroff MG, (2012). Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta, 33: 982–990.
43. Mincheva-Nilsson L, Nagaeva O, Chen T, Stendahl U, Antsiferova J, Mogren I, Hernestål J, Baranov V, (2006). Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: A possible novel immune escape mechanism for fetal survival. J. Immunol., 176: 3585–3592.
44. Riteau B, Faure F, Menier C, Viel S, Carosella ED, Amigorena S, Rouas-Freiss N, (2003). Exosomes bearing HLA-G are released by melanoma cells. Hum. Immunol., 64: 1064–1072.
45. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, Pain S, Raposo G, Benaroch P, Bonnerot C, (2002). Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int. Immunol., 14: 713–722.
46. Wajant H, Moosmayer D, Wüest T, Bartke T, Gerlach E, Schönherr U, Peters N, Scheurich P, Pfizenmaier K, (2001). Differential activation of TRAIL-R1 and −2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene, 20: 4101–4106.
47. Schneider P, Holler N, Bodmer J, Hahne M, Frei K, Fontana A, Tschopp J, (1998). Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med., 187: 1205–1213.
48. Stenqvist A-C, Nagaeva O, Baranov V, Mincheva-Nilsson L, (2013). Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J. Immunol., 191: 5515–5523.
49. Sabapatha A, Gercel-Taylor C, Taylor D, (2006). Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am. J. Reprod. Immunol., 56: 345–355.
50. Taylor D, Akyol S, Gercel-Taylor C, (2006). Pregnancy-associated exosomes and their modulation of T cell signaling. J. Immunol., 176: 1534–1542.
51. Taylor DD, Gerçel-Taylor Ç, Lyons KS, Stanson J, Whiteside TL, (2003). T-cell apoptosis and suppression of T-cell receptor/CD3-ζ by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin. Cancer Res., 9: 5113–5119.
52. del Conde I, Shrimpton C, Thiagarajan P, Lopez J, (2005). Tissue-factor-bearing microvesicles arise from lipid reafts and fuse with activated platelets to inititate coagulation. Blood, 106: 1604–1611.
53. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, de Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S, (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem., 284: 34211–34222.
54. Rubinstein E, Ziyyat A, Wolf J-P, Le Naour F, Boucheix C, (2006). The molecular players of sperm–egg fusion in mammals. Sem. Cell Dev. Biol., 17: 254–263.
55. Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, Suzuki K, Kosai K, Inoue K, Ogura A, Okabe M, Mekada E, (2000). Requirement of CD9 on the egg plasma membrane for fertilization. Science, 287: 321–324.
56. Tachibana I, Hemler ME, (1999). Role of transmembrane 4 superfamily (Tm4sf) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J. Cell Biol., 146: 893–904.
57. Takeda Y, Tachibana I, Miyado K, Kobayashi M, Miyazaki T, Funakoshi T, Kimura H, Yamane H, Saito Y, Goto H, Yoneda T, Yoshida M, Kumagai T, Osaki T, Hayashi S, Kawase I, Mekada E, (2003). Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J. Cell Biol., 161: 945–956.
58. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Hinuma Y, Yoshie O, (1992). Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol., 66: 1394–1401.
59. Booth AM, Fang Y, Fallon JK, Yang J-M, Hildreth JEK, Gould SJ, (2006). Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol., 172: 923–935.
60. Grigorov B, Attuil-Audenis V, Perugi F, Nedelec M, Watson S, Pique C, Darlix J, Conjeaud H, Muriaux D, (2009). A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology, 6: 28.
61. Sato K, Aoki J, Misawa N, Daikoku E, Sano K, Tanaka Y, Koyanagi Y, (2008). Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol., 82: 1021–1033.
62. Ho S-H, Martin F, Higginbottom A, Partridge LJ, Parthasarathy V, Moseley GW, Lopez P, Cheng-Mayer C, Monk PN, (2006). Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J. Virol., 80: 6487–6496.
63. Symeonides M, Lambele M, Roy N, Thali M, (2014). Evidence showing that tetraspanins inhibit HIV-1-induced cell-cell fusion at a post-hemifusion stage. Viruses, 6: 1078–1090.
64. Gordón-Alonso M, Yañez-Mó M, Barreiro O, Álvarez S, Muñoz-Fernández MÁ, Valenzuela-Fernández A, Sánchez-Madrid F, (2006). Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J. Immunol., 177: 5129–5137.
65. Krementsov D, Weng J, Lambele M, Roy N, Thali M, (2009). Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology, 6: 64.
66. Hemler M, (2003). Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Ann. Rev. Cell Dev. Biol., 19: 397–422.
67. Rana S, Zoller M, (2011). Exosome target cell selection and the importance of exosomal tetraspanins: A hypothesis. Biochem. Soc. Trans., 39: 559–562.
68. Feng D, Zhao W-L, Ye Y-Y, Bai X-C, Liu R-Q, Chang L-F, Zhou Q, Sui S-F, (2010). Cellular internalization of exosomes occurs through phagocytosis. Traffic, 11: 675–687.
69. Grassart A, Cheng A, Hong S, Zhang F, Zenzer N, Feng Y, Briner D, Davis G, (2014). Actin and dynamin2 dynamics and interplay during clathrin-mediated endocytosis. J. Cell Biol., 205: 721–735.
70. Gold ES, Underhill DM, Morrissette NS, Guo J, McNiven MA, Aderem A, (1999). Dynamin 2 is required for phagocytosis in macrophages. J. Exp. Med., 190: 1849–1856.
71. Jäger S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen E-L, (2004). Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci., 117: 4837–4848.
72. Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M, Regen T, Hanisch UK, Simons M, (2011). Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci., 124: 447–458.
73. Tian T, Zhu Y-L, Zhou Y-Y, Liang G-F, Wang Y-Y, Hu F-H, Xiao Z-D, (2014). Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J. Biol. Chem., 289: 22258–22267.
74. Mayor S, Pagano RE, (2007). Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol., 8: 603–612.
75. Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, Mörgelin M, Belting M, (2013). Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem., 288: 17713–17724.
76. de Bruin K, Ruthardt N, von Gersdorff K, Bausinger R, Wagner E, Ogris M, Brauchle C, (2007). Cellular dynamics of EGF receptor-targeted dynthetic viruses. Mol. Ther., 15: 1297–1305.
77. Helmuth JA, Burckhardt CJ, Koumoutsakos P, Greber UF, Sbalzarini IF, (2007). A novel supervised trajectory segmentation algorithm identifies distinct types of human adenovirus motion in host cells. J. Struct. Biol., 159: 347–358.
78. Caspi A, Yeger O, Grosheva I, Bershadsky AD, Elbaum M, (2001). A new dimension in retrograde flow: Centripetal movement of engulfed particles. Biophys. J., 81: 1990–2000.
79. Murray JW, Bananis E, Wolkoff AW, (2000). Reconstitution of ATP-dependent movement of endocytic vesicles along microtubules in vitro: An oscillatory bidirectional process. Mol. Biol. Cell, 11: 419–433.
80. Wieckowski E, Whiteside T, (2006). Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles. Immunol. Res., 36: 247–254.
81. Kim S-H, Lechman ER, Bianco N, Menon R, Keravala A, Nash J, Mi Z, Watkins SC, Gambotto A, Robbins PD, (2005). Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol., 174: 6440–6448.
82. Inglis J, Criado G, Medghalchi M, Andrews M, Sandison A, Feldmann M, Williams R, (2007). Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res. Ther., 9: R113.
83. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD, (2007). Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. J. Immunol., 179: 2242–2249.
84. Lai R, Sim Tan S, Teh B, Kwan Sze S, Arslan F, De Kleijn D, Choo A, Kiang Lim S, (2012). Proteolytic potential of the MSC exosome proteome: Implications for an exosome-mediated delivery of therapeutic proteasome. Int. J. Proteomics, 2012: 971907.